As the threat of counterfeiting continues to torment industry stakeholders and patients, more strategic approaches to ...

Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, urged public health leaders ...

A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...

According to the company's global financial results for the first quarter, released in May, declines of 19 percent in the ...

Thousands of workers at federal health agencies lost their jobs this week after a US Supreme Court ruling cleared the way for the Trump administration to move forward with major staffing cuts.

Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.

The investigative unit, which looks into potential safety issues with drugs, vaccines, medical devices, and other products, has had a retention problem for years. Inspectors leave so often that, even ...

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

Federal agency leaders still face obstacles to implementing widespread layoffs, and some are even reversing course after the ...

The number of employees laid off and companies letting people go increased year over year during the first half of 2025.

Beyond staff cuts, the departures of investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.

Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...